[1]张宏生,林月洁,陆凤娟.血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证疗效研究[J].陕西中医,2023,(7):897-900.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
　ZHANG Hongsheng,LIN Yuejie,LU Fengjuan.Clinical study on modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets in treatment of liver cancer pain of Yuxue Neizu syndrome[J].,2023,(7):897-900.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.016]
点击复制

血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年7期
页码:
897-900
栏目:
临床研究
出版日期:
2023-07-05

文章信息/Info

Title:
Clinical study on modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets in treatment of liver cancer pain of Yuxue Neizu syndrome
作者:
张宏生; 林月洁; 陆凤娟
(柳州市工人医院,广西 柳州 545007)
Author(s):
ZHANG Hongsheng; LIN Yuejie; LU Fengjuan
(Liuzhou Worker' s Hospital,Liuzhou 545007,China)
关键词:
肝癌;  癌痛;  瘀血内阻;  血府逐瘀汤;  盐酸吗啡缓释片;  镇痛;  生活质量
Keywords:
Liver cancer;  Cancer pain;  Yuxue Neizu;  Xuefu Zhuyu decoction;  Morphine hydrochloride sustained-release tablets;  Analgesia;  Quality of life
分类号:
R 273
DOI:
DOI:10.3969/j.issn.1000-7369.2023.07.016
文献标志码:
A
摘要:
目的:探讨血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证临床疗效。方法:选取肝癌疼痛瘀血内阻证患者108例,按照随机信封法分为两组,对照组(n=54)给予盐酸吗啡缓释片治疗,观察组(n=54)给予血府逐瘀汤加减联合盐酸吗啡缓释片治疗。比较两组患者镇痛效果、疼痛评分、中医症状积分、镇痛因子以及生活质量。结果:治疗4周后观察组疼痛有效缓解率高于对照组(P<0.05)。治疗前、治疗2周后,两组患者数字疼痛分级量表(NRS)评分比较,差异无统计学意义(均P>0.05)。治疗3、4周后,观察组NRS评分低于对照组,差异有统计学意义(P<0.05)。治疗前两组患者肝区疼痛、腹内癥块、纳呆、情志抑郁中医症状积分比较,差异无统计学意义(均P>0.05)。治疗4周后观察组各项中医症状积分均低于对照组,差异有统计学意义(P<0.05)。治疗4周后观察组PGE2、NO低于对照组,差异有统计学意义(均P<0.05)。治疗4周后观察组QLQ-30量表各维度高于对照组,差异有统计学意义(均P<0.05)。结论:血府逐瘀汤加减联合盐酸吗啡缓释片治疗肝癌疼痛瘀血内阻证患者可降低镇痛因子水平,提升镇痛效果,缓解中医症状,改善生活质量。
Abstract:
Objective:To explore clinical efficacy of modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets in the treatment of patients with liver cancer pain of Yuxue Neizu syndrome.Methods:108 patients with liver cancer pain of Yuxue Neizu syndrome selected and divided into two groups according to the random envelope method,control group(n=54)morphine hydrochloride sustained-release tablets treatment and observation group(n=54)modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets treatment.Comparisons were performed on the two groups in terms of analgesic effect,pain score,TCM symptoms scores,analgesic factors and quality of life.Results:After 4 weeks of treatment,the effective relief rate of pain in the observation group was higher than that in the control group(P<0.05).Before treatment and 2 weeks after treatment,there was no significant difference in the score of NRS between the two groups(all P>0.05).The NRS scores at 3 weeks and 4 weeks after treatment in the observation group were lower than those in the control group,difference statistically significant(P<0.05).There were no significant differences in the scores of TCM symptoms such as hepatalgia,intra-abdominal mass,anorexia and emotional depression between the two groups before treatment(all P>0.05).After 4 weeks of treatment,the above TCM symptoms scores in the observation group were lower than those in the control group,difference statistically significant(all P<0.05).After 4 weeks of treatment,the levels of PGE2 and NO in the observation group were lower than those in the control group(P<0.05).The above scores of QLQ-30 scale after 4 weeks of treatment were higher in the observation group than those in the control group,difference statistically significant(all P<0.05).Conclusion:Modified Xuefu Zhuyu decoction supplemented with morphine hydrochloride sustained-release tablets can reduce levels of body's analgesic factors,enhance clinical analgesic effect,relieve TCM symptoms,improving quality of life in treatment of patients with liver cancer pain of Yuxue Neizu syndrome.

参考文献/References:

[1] 徐 畅,黄铄淇,田才智,等.肝癌药物联合治疗进展[J].中国临床实用医学,2021,12(6):72-74.
[2] 李玉龙,宗 伟,常素娥,等.微小RNA-195通过靶向BIRC5调控肝癌Hep3B细胞凋亡实验研究[J].陕西医学杂志,2022,51(3):270-273,279.
[3] 梁宾勇,黄志勇,陈孝平.新开发药物的临床应用对肝癌外科治疗决策的影响[J].临床外科杂志,2021,29(11):1001-1003.
[4] 吴笑杰,兰锐军,陆 明.癌痛的中医药治疗进展[J].新疆中医药,2021,39(2):98-100.
[5] 丁玉霞,李素领.李素领教授辨治原发性肝癌肝癌疼痛经验[J].中西医结合肝病杂志,2021,31(1):87-89.
[6] 肖 岚,朱 宏,张 婷,等.董克礼教授治疗原发性肝癌临床经验[J].陕西中医,2020,41(11):1639-1642.
[7] 张 荣,马继征,刘慧敏,等.血府逐瘀汤治疗消化系统疾病3例[J].北京中医药,2020,39(1):92-94.
[8] 张琳婧,闫占峰,矫璐璐,等.血府逐瘀汤在耳鼻咽喉疾病中的应用[J].中国医药导报,2020,17(19):120-122,139.
[9] 中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗指南[J].中华消化外科杂志,2022,21(2):143-168.
[10] 周仲瑛.中医内科学[M].北京:中国中医药出版社,2003:474,469.
[11] 李春蕊,张 雯,樊碧发.数字评分法与口述评分法(VRS)在老年慢性疼痛患者中的比较[J].中国疼痛医学杂志,2016,22(9):683-686.
[12] 刘可可,吴倍华,乔依白,等.晚期癌症患者的社区三阶梯疼痛治疗效果评价[J].中国医药导刊,2020,22(9):599-603.
[13] 闫芍药,聂会勇,王锁良.加味双柏散外敷联合耳穴压豆对肝癌介入治疗患者疼痛评分及生活质量影响[J].陕西中医,2020,41(12):1763-1766.
[14] 夏小健,张进科,黄 蓓,等.气血舒服散治疗晚期肺癌癌因性疲乏患者气血两虚证36例[J].环球中医药,2021,14(7):1332-1335.
[15] 高颖妍.血府逐瘀汤治疗原发性肝癌气滞血瘀型癌痛的疗效观察[D].广州:广州中医药大学,2020.
[16] 卢冬彦,叶小卫.血府逐瘀汤治疗原发性肝癌TACE术后气滞血瘀型疼痛30例[J].安徽中医药大学学报,2016,35(1):45-47.
[17] 陈杰华,马海燕.盐酸氢吗啡酮应用于腹腔镜胆囊切除术老年患者对气管插管应激反应和围术期细胞因子的影响[J].陕西医学杂志,2017,46(7):955-957.
[18] 林镜宏.大剂量盐酸羟考酮缓释片与硫酸吗啡缓释片治疗重度癌痛对P物质、β-内啡肽、5-羟色胺指标的影响对比[J].吉林医学,2022,43(8):2149-2150.
[19] 戴勍男,唐轶珣,胡 霞,等.鞘内单次与连续输注吗啡镇痛对晚期癌痛患者吗啡用量及白细胞介素-1β、白细胞介素-6、肿瘤坏死因子-α水平的影响[J].中华实验外科杂志,2023,40(2):360-364.
[20] 黄朝卫,杨 洋.腕踝针联合血府逐淤汤治疗急性腰扭伤的临床效果及其对血液学炎性反应指标的影响[J].世界中医药,2017,12(9):2168-2171.
[21] 张生茂,李 娜,包娜日素,等.盐酸氢吗啡酮治疗骨癌痛患者的临床效果及对疼痛相关介质和激素水平的影响[J].中国医药导报,2022,19(1):119-122,127.
[22] 杨 宇,史昌乾,佟 杰.羟基红花黄色素A镇痛作用及机制初步研究[J].中南药学,2019,17(1):53-56.
[23] 王志洲,邹德宝,石 威,等.基于网络药理学和实验验证探讨淫羊藿苷经MAPK信号通路防治激素性股骨头坏死的作用机制[J].湖南中医药大学学报,2022,42(10):1749-1756.
[24] 王 鹏,刘 欣,郭树豫,等.四君子加川牛膝方对大鼠下肢难愈性创面血小板衍化生长因子表达的影响[J].陕西中医,2020,41(2):139-142.
[25] 林平冬,翁霞萍,刘发元,等.牛膝有效成分防治骨关节炎的作用机制探讨[J].风湿病与关节炎,2015,4(2):56-59.
[26] 母传贤,刘国玲,田 华,等.川芎嗪对胶原性关节炎大鼠血清IL-1、IL-6、IL-2水平及关节浸液NO、PGE2的影响[J].中国中西医结合杂志,2014,34(2):214-217.
[27] 谢平金,罗 臻,卢启贵,等.川芎嗪和过表达miR-20b-5p干预早期膝骨关节炎模型大鼠滑膜、软骨和软骨下骨血管新生的组织学变化[J].中国组织工程研究,2023,27(2):237-245.
[28] 孙银平,张大伟,郭 勇,等.川芎嗪对血管再狭窄大鼠血小板源生长因子受体与细胞外信号调节蛋白激酶表达的影响[J].陕西医学杂志,2009,38(4):390-391,395.
[29] 付佳琪,蔡治国,于漫亚,等.基于网络药理学及全转录组测序对当归四逆汤干预外泌体抑制多发性骨髓瘤血管新生的机制研究[J].湖南中医药大学学报,2022,42(1):120-128.
[30] 史 宁,郭宏举,耿 帅,等.超高效液相色谱串联四级杆飞行时间质谱快速测定天王补心片中五味子醇甲和藁本内酯含量[J].陕西中医,2020,41(2):251-253.
[31] 何树苗,陈元堃,曾 奥,等.藁本内酯药理作用及机制研究进展[J].广东药科大学学报,2021,37(2):152-156.

相似文献/References:

[1]高建清,雷艳容,陈红蓓.中药外敷痛点及腧穴配合针刺对晚期肺癌患者癌痛程度、睡眠质量的影响*[J].陕西中医,2020,(7):972.[doi:DOI:10.3969/j.issn.10007369.2020.07.041]
　GAO Jianqing,LEI Yanrong,CHEN Hongbei..Effect of external application of Chinese medicine at pain points and acupoints combined with acupuncture on reducing cancer pain level and sleep quality of patients with advanced lung cancer[J].,2020,(7):972.[doi:DOI:10.3969/j.issn.10007369.2020.07.041]
[2]肖 岚,朱 宏,张 婷,等.董克礼教授治疗原发性肝癌临床经验*[J].陕西中医,2020,(11):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
　XIAO Lan,ZHU Hong,ZHANG Ting,et al.Experience of professor DONG Keli for treating primary liver cancer[J].,2020,(7):1639.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.032]
[3]王 军,徐建良,杜燕红.扶正祛邪汤对肝癌模型大鼠肠道菌群微生态环境的作用研究[J].陕西中医,2021,(2):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
　WANG Jun,XU Jianliang,DU Yanhong.Effect of Fuzheng Quxie decoction on intestinal microflora microecological environment of liver cancer model rats[J].,2021,(7):143.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.002]
[4]朱玉辉,柴 劲.黄芪补气汤联合还原型谷胱甘肽对肝癌介入治疗后患者肝功能、氧化应激及炎症的影响[J].陕西中医,2021,(5):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
　ZHU Yuhui,CHAI Jin.Effect of Huangqi Buqi decoction combined with reduced glutathione on liver function,oxidative stress and inflammation after interventional therapy for hepatocellular carcinoma[J].,2021,(7):570.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.006]
[5]周 锐,马灏川,陈亚栋,等.针灸辅助治疗胃癌现状及展望[J].陕西中医,2021,(8):1150.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.040]
　ZHOU Rui,MA Haochuan,CHEN Yadong,et al.Review of acupuncture and moxibusition on gastric cancer[J].,2021,(7):1150.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.040]
[6]刘振方,孙巧玉,孟祥彩,等.黄芩素下调微小RNA-130a抑制肝癌细胞侵袭机制研究[J].陕西中医,2021,(12):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
　LIU Zhenfang,SUN Qiaoyu,MENG Xiangcai,et al.Study on mechanism of baicalein down-regulating miR-130a to inhibit hepatocellular carcinoma invasion[J].,2021,(7):1667.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.003]
[7]李武浩,许尤琪.中医药防治肝动脉灌注化疗相关不良反应研究进展[J].陕西中医,2022,(5):673.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.031]
　LI Wuhao,XU Youqi.Clinical research progress of traditional Chinese medicine on the prevention and treatment of related adverse reaction of hepatic artery infusion chemotherapy[J].,2022,(7):673.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.031]
[8]陈 嵘,李淑敏,李旭华,等.软坚散结方调控小鼠HIF-1α 糖酵解分子转导抑制肝肿瘤细胞增殖机制研究[J].陕西中医,2023,(7):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
　CHEN Rong,LI Shumin,LI Xuhua,et al.Mechanism study on Ruanjian Sanjie prescription inhibit proliferation of liver cancer cells through regulating HIF-1α pathway[J].,2023,(7):839.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.003]
[9]刘 鹏,陈青山,杨建波.柴胡疏肝散加减联合射频消融治疗肝癌疗效研究[J].陕西中医,2023,(7):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
　LIU Peng,CHEN Qingshan,YANG Jianbo.Curative effect study on Chaihu Shugan powder combined with radiofrequency ablation for liver cancer[J].,2023,(7):892.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.015]
[10]孔庆旭,陈桂云,陈自力,等.槲芪方加减对肝癌化疗栓塞术后大鼠一氧化氮合酶、血管内皮生长因子、乏氧及免疫功能的影响[J].陕西中医,2024,(2):181.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.007]
　KONG Qingxu,CHEN Guiyun,CHEN Zili,et al.Effects of Huqi formula on iNOS,VEGF,hypoxia and immune function of rats after chemoembolization for liver cancer[J].,2024,(7):181.[doi:DOI:10.3969/j.issn.1000-7369.2024.02.007]

备注/Memo

备注/Memo:
基金项目:广西壮族自治区中医药管理局科研课题(GXZYB20220439)
更新日期/Last Update: 2023-07-10